I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cresti, N.
34
results:
Search for persons
X
Format
Online (34)
Mediatypes
Articles (Online) (21)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
232P Real-world study of sacituzumab govitecan in metastati..:
Hanna, D.
;
Merrick, S.
;
Ghose, A.
...
ESMO Open. 8 (2023) 1 - p. 101420 , 2023
Link:
https://doi.org/10.1016/..
?
2
Author Correction: Results of the phase IIa RADICAL trial o..:
Coombes, R. C.
;
Badman, P. D.
;
Lozano-Kuehne, J. P.
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
Results of the phase IIa RADICAL trial of the FGFR inhibito..:
Coombes, R. C.
;
Badman, P. D.
;
Lozano-Kuehne, J. P.
...
Nature Communications. 13 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
4
North East Experience on Pertuzumab, Trastuzumab and Doceta..:
Mariappan, L.
;
Veeratterapillay, J.
;
Cresti, N.
...
Clinical Oncology. 32 (2020) 8 - p. e171-e172 , 2020
Link:
https://doi.org/10.1016/..
?
5
Phase 1 dose-escalation study of S-222611, an oral reversib..:
Spicer, J.
;
Baird, R.
;
Suder, A.
...
European Journal of Cancer. 51 (2015) 2 - p. 137-145 , 2015
Link:
https://doi.org/10.1016/..
?
6
Cardiac troponin release following standard dose anthracycl..:
Haney, S.
;
Cresti, N.
;
Verrill, M.
.
European Heart Journal. 34 (2013) suppl 1 - p. P5752-P5752 , 2013
Link:
https://doi.org/10.1093/..
?
7
Author Correction: Results of the phase IIa RADICAL trial o..:
Coombes, RC
;
Badman, PD
;
Lozano-Kuehne, JP
...
Nature Communications. , 2023
Link:
http://hdl.handle.net/10..
?
8
Author Correction: Results of the phase IIa RADICAL trial o..:
Coombes, R. C
;
Badman, P. D
;
Lozano-Kuehne, J. P
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845345/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
Results of the phase IIa RADICAL trial of the FGFR inhibito..:
Coombes, RC
;
Badman, PD
;
Lozano-Kuehne, JP
...
https://www.repository.cam.ac.uk/handle/1810/338357. , 2022
Link:
https://www.repository.c..
?
10
Results of the phase IIa RADICAL trial of the FGFR inhibito..:
Coombes, R.C
;
Badman, P.D
;
Lozano-Kuehne, J.P
...
https://eprints.gla.ac.uk/272950/1/272950.pdf. , 2022
Link:
https://eprints.gla.ac.u..
?
11
Results of the phase IIa RADICAL trial of the FGFR inhibito..:
Coombes, R. C
;
Badman, P. D
;
Lozano-Kuehne, J. P
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187670/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
12
Results of the Phase IIa RADICAL trial of the FGFR inhibito..:
Coombes, R
;
Badman, P
;
Lozano-Kuehne, JP
...
Nature Communications. , 2022
Link:
http://hdl.handle.net/10..
?
13
A phase 1b/2, open-label, dose-escalation, and dose-confirm..:
Twelves, C
;
Anthoney, A
;
Savulsky, CI
...
https://eprints.whiterose.ac.uk/148290/1/s41416-018-0366-5.pdf. , 2019
Link:
https://eprints.whiteros..
?
14
Author Correction: Results of the phase IIa RADICAL trial o..:
R. C. Coombes
;
P. D. Badman
;
J. P. Lozano-Kuehne
...
https://doi.org/10.1038/s41467-023-35969-4. , 2023
Link:
https://doi.org/10.1038/..
?
15
Results of the phase IIa RADICAL trial of the FGFR inhibito..:
R. C. Coombes
;
P. D. Badman
;
J. P. Lozano-Kuehne
...
https://doi.org/10.1038/s41467-022-30666-0. , 2022
Link:
https://doi.org/10.1038/..
1-15
